Production (Stage)
The Oncology Institute, Inc.
TOI
$3.02
$0.031.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.59M | -13.18M | -16.11M | -15.48M | -19.89M |
| Total Depreciation and Amortization | 1.78M | 1.71M | 1.57M | 1.52M | 1.49M |
| Total Amortization of Deferred Charges | 4.87M | 1.59M | 1.59M | 1.57M | 1.56M |
| Total Other Non-Cash Items | 4.81M | 1.33M | 2.31M | 142.00K | 3.69M |
| Change in Net Operating Assets | 3.13M | 12.73M | 11.46M | -3.41M | -2.73M |
| Cash from Operations | -4.99M | 4.19M | 819.00K | -15.66M | -15.88M |
| Capital Expenditure | -328.00K | -1.76M | 402.00K | -1.83M | -610.00K |
| Sale of Property, Plant, and Equipment | 126.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 10.00M | 20.00M | 20.00M |
| Cash from Investing | -202.00K | -1.76M | 10.40M | 18.18M | 19.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.24M | -1.17M | 991.00K | -9.00K | -1.01M |
| Issuance of Common Stock | 15.50M | 0.00 | 0.00 | 2.00K | 73.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 1.00M | -1.23M | -2.14M | -- |
| Cash from Financing | -4.74M | -164.00K | -243.00K | -2.15M | -938.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.93M | 2.27M | 10.98M | 369.00K | 2.57M |